Tatva Chintan Pharma Chem has informed that the ‘Trading Window’ for dealing in the securities of the Company shall remain closed for all Designated Persons and their immediate relatives from Thursday, 01 January 2026 till the completion of 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and nine months ending 31 December 2025. Accordingly, all Designated Persons and their immediate relatives of the Company have been advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.
